Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Merck sells OTC operations to Bayer for $14.2bn

Executive Summary

Edging out other rumored bidders including Reckitt Benckiser and Procter & Gamble, Bayer AG acquired Merck & Co. Inc.’s consumer business for $14.2bn. A portion of that payment is related to sales of Merck’s allergy product Claritin and Afrin nasal decongestant spray in certain countries where they are still only available via prescriptions.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies